Inventor · disambiguated record
James J. Mulé
Also filed as: MULE' JAMES J · MULÉ JAMES · MULÉ JAMES J
8 granted patents·11 pending applications·25 citations·filing 2009–2024
83Inventor score
Files withH LEE MOFFITT CANCER CT & RES13MULE JAMES J2H LEE MOFFIT CANCER CENTER AND RES INSTITUTE INC1H LEE MOFFITT CANCER CT AND RES INSTITUTUTE INC1MULÉ JAMES J1
Top patents by PatentIndex Score
19 records- 0182US10041129B2Immune gene signatures in cancerH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Aug 7, 2018·3 cites·15 claims
- 0280US10648040B2Immune gene signatures in treating breast cancerH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted May 12, 2020·1 cites·15 claims
- 0377US11401506B2Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Aug 2, 2022·1 cites·15 claims
- 0477US9404926B2Immune gene signatures in cancerMULÉ JAMES J·Filed 2011·Granted Aug 2, 2016·5 cites·21 claims
- 0577US8597946B2Enhanced dendritic cells for cancer immunotherapyMULE JAMES J·Filed 2009·Granted Dec 3, 2013·10 cites·13 claims
- 0674US10583183B2Immune gene signatures in urothelial carcinoma (UC)H LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Mar 10, 2020·2 cites·4 claims
- 0772US9234175B2Creating bioengineered lymph nodesMULE JAMES J·Filed 2010·Granted Jan 12, 2016·3 cites·26 claims
- 0871US2021381061A1Immune Gene Signatures in CancerH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 0968US2022340874A1Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell TherapyH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1067US2020399706A1Immune Gene Signatures in CancerH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 1166US2011059137A1Chemokine gene-modified cells for cancer immunotherapyH LEE MOFFITT CANCER CT AND RES INSTITUTUTE INC·Filed 2009·Application pending·0 cites
- 1262US2025179145A1Chimeric antigen receptor tumor infiltrating lymphocytesH LEE MOFFIT CANCER CENTER AND RES INSTITUTE INC·Filed 2024·Application pending·0 cites
- 1357US2013251752A1Chemokine gene-modified cells for cancer immunotherapyUNIV SOUTH FLORIDA·Filed 2013·Application pending·0 cites
- 1455US2021244760A1Chimeric antigen receptor tumor infiltrating lymphocytesH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 1554US2024336893A1Gene signature predicting tertiary lymphoid structures containing b cellsH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1652US12383604B2Bioengineering tertiary lymphoid structures using chitosan-based hydrogelsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 12, 2025·0 cites·8 claims
- 1752US2023086675A1Tumor-infiltrating lymphocytes with enhanced tumor reactivityH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1846US2023323468A1Immune gene signatures in muscle invasive bladder cancerH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1942US2015154368A1Methods and apparatuses using molecular fingerprints to provide targeted therapeutic strategiesH LEE MOFFITT CANCER CT & RES·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James J. Mulé files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →